Zimmer formalizes a deal with SpineCraft the rights to its Apex spinal screw device, launching sales in the U.S., Canada, New Zealand and Australia.
With Zimmer (NYSE:ZMH) still reeling from a 10% slide in its spine business, the orthopedic device maker announced a deal with SpineCraft, maker of the Apex spine correction device.
The long-term distribution deal allows Zimmer Spine to market Apex in the U.S., Canada, New Zealand and Australia, according to a press release.
SpineCraft’s Apex device, which won FDA 510(k) clearance in 2006, is a screw system that stabilizes spinal deformities. Zimmer said the deal is part of an expanding portfolio for its spine department.
